Hisaya Akiba Selected Research

Hisaya Akiba Research Topics

Disease

10	Neoplasms (Cancer) 10/2023 - 02/2004
9	Asthma (Bronchial Asthma) 11/2023 - 04/2003
7	Inflammation (Inflammations) 11/2023 - 03/2011
4	Reperfusion Injury 03/2011 - 04/2010
3	Pneumonia (Pneumonitis) 12/2017 - 09/2012
3	Experimental Arthritis 03/2011 - 10/2002
3	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 01/2008 - 02/2007
3	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2006 - 07/2002
3	Eosinophilia 02/2004 - 07/2003
2	Melanoma (Melanoma, Malignant) 07/2020 - 04/2013
2	Fibrosis (Cirrhosis) 12/2017 - 01/2016
2	Infections 07/2014 - 10/2003
2	Lupus Nephritis 05/2014 - 09/2003
2	Autoimmune Diseases (Autoimmune Disease) 05/2014 - 07/2002
2	Arthritis (Polyarthritis) 11/2013 - 10/2002
2	Contact Dermatitis (Eczema, Contact) 02/2012 - 10/2003
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2012 - 07/2003
2	Ischemia 03/2011 - 04/2010
2	Uveitis 10/2010 - 04/2009
2	Hypersensitivity (Allergy) 04/2009 - 07/2003
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 07/2007 - 07/2003
2	Neoplasm Metastasis (Metastasis) 06/2006 - 03/2005
2	Colitis 10/2003 - 02/2003
1	Ovarian Neoplasms (Ovarian Cancer) 10/2023
1	Obesity 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Respiratory Hypersensitivity 07/2021
1	Asbestosis 01/2021
1	Granuloma 01/2021
1	Immune System Diseases (Immune Disorders) 01/2016
1	Vascular Remodeling 01/2015
1	Lymphadenopathy 05/2014
1	Proteinuria 05/2014
1	Bone Resorption 11/2013
1	Atherosclerosis 11/2013
1	Experimental Melanoma 04/2013
1	Glomerulonephritis 05/2012
1	Acute Kidney Injury (Acute Renal Failure) 11/2011

Drug/Important Bio-Agent (IBA)

13	Monoclonal AntibodiesIBA 07/2020 - 02/2003
9	Immunoglobulins (Immunoglobulin)IBA 05/2014 - 04/2010
8	CytokinesIBA 01/2018 - 04/2003
6	MucinsIBA 12/2013 - 02/2007
5	Proteins (Proteins, Gene)FDA Link 11/2013 - 10/2002
5	LigandsIBA 07/2010 - 10/2003
4	OvalbuminIBA 11/2023 - 04/2003
4	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2016
4	Mucin-1 (CA 15-3 Antigen)IBA 05/2014 - 02/2008
4	AntibodiesIBA 05/2012 - 02/2007
3	Messenger RNA (mRNA)IBA 11/2023 - 02/2012
3	Interleukin-10 (Interleukin 10)IBA 07/2014 - 10/2003
3	AntigensIBA 05/2012 - 07/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2005 - 10/2003
3	AllergensIBA 02/2004 - 04/2003
2	Immunoglobulin E (IgE)IBA 01/2018 - 10/2003
2	DNA (Deoxyribonucleic Acid)IBA 05/2014 - 09/2012
2	Therapeutic UsesIBA 11/2013 - 04/2013
2	HaptensIBA 02/2012 - 10/2003
2	Mucin-3IBA 02/2012 - 12/2010
2	InterferonsIBA 02/2012 - 06/2006
2	CarcinogensIBA 05/2011 - 06/2006
2	Interleukin-17 (Interleukin 17)IBA 10/2010 - 07/2007
2	TNF-Related Apoptosis-Inducing LigandIBA 06/2006 - 03/2005
1	Mitogen-Activated Protein KinasesIBA 11/2023
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 11/2023
1	Chemokine CCL5IBA 11/2023
1	fibroblast growth factor 18IBA 10/2023
1	mepolizumabIBA 06/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2023
1	benralizumabIBA 01/2023
1	Interleukin-33IBA 01/2022
1	SteroidsIBA 07/2021
1	ChitinIBA 07/2021
1	Carbon Nanotubes (Carbon Nanotube)IBA 01/2021
1	InflammasomesIBA 01/2021
1	ChemokinesIBA 01/2018
1	PeriostinIBA 01/2018
1	TenascinIBA 01/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 12/2017
1	Immune Checkpoint InhibitorsIBA 12/2017
1	Immunoglobulin G (IgG)IBA 12/2017
1	Cysteine Proteases (Cysteine Protease)IBA 08/2015
1	Interleukin-5 (Interleukin 5)IBA 08/2015
1	Interleukin-13IBA 08/2015
1	Glycoproteins (Glycoprotein)IBA 12/2013
1	CollagenIBA 11/2013
1	LipidsIBA 11/2013
1	flt3 ligand protein (flt3 ligand)IBA 04/2013
1	VaccinesIBA 04/2013
1	Cancer VaccinesIBA 04/2013
1	AlarminsIBA 09/2012
1	HMGB1 Protein (HMG1)IBA 09/2012
1	Nucleic AcidsIBA 09/2012
1	GlobulinsIBA 05/2012
1	Cisplatin (Platino)FDA LinkGeneric 11/2011
1	Metalloproteases (Metalloproteinases)IBA 08/2011

Therapy/Procedure

5	Immunotherapy 12/2017 - 06/2006
4	Therapeutics 01/2016 - 07/2003
3	Drug Therapy (Chemotherapy) 12/2013 - 11/2011
1	Aftercare (After-Treatment) 01/2023
1	Radiotherapy 07/2020